h-d-phe-pip-arg-pna has been researched along with rivaroxaban in 1 studies
Studies (h-d-phe-pip-arg-pna) | Trials (h-d-phe-pip-arg-pna) | Recent Studies (post-2010) (h-d-phe-pip-arg-pna) | Studies (rivaroxaban) | Trials (rivaroxaban) | Recent Studies (post-2010) (rivaroxaban) |
---|---|---|---|---|---|
95 | 1 | 5 | 4,741 | 569 | 4,357 |
Protein | Taxonomy | h-d-phe-pip-arg-pna (IC50) | rivaroxaban (IC50) |
---|---|---|---|
Coagulation factor X | Homo sapiens (human) | 0.0038 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, S; Harenberg, J; Krämer, R; Krämer, S; Wehling, M; Weiss, C | 1 |
1 other study(ies) available for h-d-phe-pip-arg-pna and rivaroxaban
Article | Year |
---|---|
Measurement of Non-Vitamin K Antagonist Oral Anticoagulants in Patient Plasma Using Heptest-STAT Coagulation Method.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Blood Coagulation; Dabigatran; Dipeptides; Enzyme Assays; Factor Xa Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Vitamin K; Whole Blood Coagulation Time | 2015 |